288 related articles for article (PubMed ID: 27168367)
21. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization.
Shi X; Semkova I; Müther PS; Dell S; Kociok N; Joussen AM
Exp Eye Res; 2006 Dec; 83(6):1325-34. PubMed ID: 16959248
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of fibrosis inhibition in laser induced choroidal neovascularization by doxycycline.
Peng X; Xiao H; Tang M; Zhan Z; Yang Y; Sun L; Luo X; Zhang A; Ding X
Exp Eye Res; 2018 Nov; 176():88-97. PubMed ID: 30008391
[TBL] [Abstract][Full Text] [Related]
25. Correlation of CD105 and vascular endothelial growth factor in laser-induced choroidal neovascularization in rats.
Xu J; Wang Y; Yang X; Zhang P; Chen L
Yan Ke Xue Bao; 2006 Sep; 22(3):166-74, 183. PubMed ID: 17162902
[TBL] [Abstract][Full Text] [Related]
26. The antiangiogenic effects of integrin alpha5beta1 inhibitor (ATN-161) in vitro and in vivo.
Wang W; Wang F; Lu F; Xu S; Hu W; Huang J; Gu Q; Sun X
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7213-20. PubMed ID: 21813636
[TBL] [Abstract][Full Text] [Related]
27. CNTF Prevents Development of Outer Retinal Neovascularization Through Upregulation of CxCl10.
Bucher F; Aguilar E; Marra KV; Rapp J; Arnold J; Diaz-Aguilar S; Lange C; Agostini H; Schlunck G; Stahl A; Friedlander M
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):20. PubMed ID: 32780864
[TBL] [Abstract][Full Text] [Related]
28. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
29. Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization.
Schnabolk G; Coughlin B; Joseph K; Kunchithapautham K; Bandyopadhyay M; O'Quinn EC; Nowling T; Rohrer B
Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1850-63. PubMed ID: 25593023
[TBL] [Abstract][Full Text] [Related]
30. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.
Wakusawa R; Abe T; Sato H; Sonoda H; Sato M; Mitsuda Y; Takakura T; Fukushima T; Onami H; Nagai N; Ishikawa Y; Nishida K; Sato Y
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3272-80. PubMed ID: 21345982
[TBL] [Abstract][Full Text] [Related]
31. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283
[TBL] [Abstract][Full Text] [Related]
32. Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice.
Kang S; Roh CR; Cho WK; Park KC; Yang KJ; Choi HS; Kim SH; Roh YJ
Curr Eye Res; 2013 Jan; 38(1):119-27. PubMed ID: 23013553
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo.
Liu X; Zhu M; Yang X; Wang Y; Qin B; Cui C; Chen H; Sang A
Exp Mol Pathol; 2016 Jun; 100(3):451-9. PubMed ID: 27112838
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy.
Dal Monte M; Cammalleri M; Pecci V; Carmosino M; Procino G; Pini A; De Rosa M; Pavone V; Svelto M; Bagnoli P
J Cell Mol Med; 2019 Feb; 23(2):1034-1049. PubMed ID: 30426662
[TBL] [Abstract][Full Text] [Related]
35. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression.
Lavine JA; Farnoodian M; Wang S; Darjatmoko SR; Wright LS; Gamm DM; Ip MS; Sorenson CM; Sheibani N
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):299-308. PubMed ID: 28114591
[TBL] [Abstract][Full Text] [Related]
36. Effect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse.
Maestroni S; Maestroni A; Ceglia S; Tremolada G; Mancino M; Sacchi A; Lattanzio R; Zucchiatti I; Corti A; Bandello F; Zerbini G
Acta Ophthalmol; 2015 May; 93(3):e218-22. PubMed ID: 25271003
[TBL] [Abstract][Full Text] [Related]
37. Anti-angiogenic effect of the basement membrane protein nidogen-1 in a mouse model of choroidal neovascularization.
Semkova I; Kociok N; Karagiannis D; Nischt R; Smyth N; Paulsson M; Strauß O; Joussen AM
Exp Eye Res; 2014 Jan; 118():80-8. PubMed ID: 24280453
[TBL] [Abstract][Full Text] [Related]
38. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
[TBL] [Abstract][Full Text] [Related]
39. Intravenous injection of l-aspartic acid β-hydroxamate attenuates choroidal neovascularization via anti-VEGF and anti-inflammation.
Wu M; Liu Y; Zhang H; Lian M; Chen J; Jiang H; Xu Y; Shan G; Wu S
Exp Eye Res; 2019 May; 182():93-100. PubMed ID: 30917905
[TBL] [Abstract][Full Text] [Related]
40. Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344.
Xie P; Kamei M; Suzuki M; Matsumura N; Nishida K; Sakimoto S; Sakaguchi H; Nishida K
PLoS One; 2011; 6(12):e28933. PubMed ID: 22205983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]